Key Takeaways
- GDM will acquire 100% of AgReliant Genetics from Vilmorin & Cie and KWS
- AgReliant is a major North American seed company specializing in corn and soybean
- Vilmorin & Cie retains corn germplasm and continues U.S. and Canadian seed operations
- The transaction aligns with GDM’s expansion strategy and Vilmorin & Cie’s strategic refocusing
- The announcement follows recent news that Vilmorin & Cie’s subsidiary, Limagrain, entered talks to sell 35% to ADQ
GDM to Strengthen North American Presence with AgReliant Acquisition
GDM, a global leader in soybean genetics, has entered into a binding agreement to acquire AgReliant Genetics by purchasing the remaining 50% stakes held by Vilmorin & Cie and KWS, who co-founded the joint venture in 2000. The transaction will make GDM the sole owner of AgReliant, enhancing its footprint in the North American corn and soybean seed market.
AgReliant has grown to become a prominent seed company across the U.S. and Canada, focusing on research, production, and commercialization of high-value crops. Under GDM’s ownership, the company will continue its operations with the added benefit of GDM’s global R&D capabilities.
Vilmorin & Cie to Retain Germplasm and Refocus on Strategic Priorities
While exiting its 25-year joint venture, Vilmorin & Cie will retain ownership of all co-developed corn germplasm and maintain its other seed operations in the U.S. and Canada. The move supports Vilmorin & Cie’s Ambition 2030 roadmap, which includes realignment toward strategic territories and enhanced innovation through breeding and partnerships.
This announcement comes shortly after news that Limagrain, Vilmorin & Cie’s field seeds subsidiary, has entered into discussions to sell a 35% stake to ADQ, the Abu Dhabi-based investment and holding company. That potential transaction, if completed, would further signal Vilmorin & Cie’s broader portfolio optimization strategy.
GDM to Integrate AgReliant into its Global Growth Strategy
The acquisition of AgReliant reflects GDM’s continued commitment to innovation and market expansion. The company’s integration of AgReliant is expected to enhance its ability to deliver advanced seed genetics to North American growers, particularly in corn and soybean crops.
The deal is subject to regulatory approvals and standard closing conditions, with completion anticipated in the third quarter of 2025. Financial terms of the transaction remain confidential, though Vilmorin & Cie disclosed the deal value for its stake is in the low hundreds of millions (USD) range.
